Optune® Buddy Program

Talk to someone who knows what Optune is like

If you or a loved one is considering or has recently started Optune, it may help to talk to someone who has experience with Optune. You can connect directly with users and/or caregivers who want to share what they’ve learned with you.*

The Optune Buddy Program has offered me an opportunity to provide hope and encouragement to others who are battling glioblastoma. – Jeanneane, an Optune user

Learn more about her

Novocure® can connect you with an Optune user or caregiver by phone or video chat. For up to 60 minutes you can:

  • Talk to a current user (Patient Ambassador) about personal experiences with GBM and Optune
  • Talk to another caregiver (Caregiver Ambassador) about how to navigate challenges and find support resources

To schedule a call or video chat with an Optune Ambassador, call or register online.*

Call 1-844-247-1636 and a member of the Novocure team will schedule your session.

Ensure that your information is correct so that we can contact you. All fields are required.

I am a patient/caregiver Other
Conference call Video chat
By clicking here, I am agreeing to the statements below and confirm that I have read and accept Novocure’s Privacy Policy. I also affirm that I am at least eighteen (18) years of age or older. I authorize Novocure Inc. (Novocure), its affiliates, and companies working with Novocure to contact me by direct mail, email, telephone, and electronic message (including autodialed and pre-recorded calls and messages) for marketing purposes, such as: to keep me informed about products and patient support services; to provide me special offers regarding Novocure products and programs; to conduct market research or surveys; or other opportunities that may be of interest to me. I further understand that the information that I share with Novocure may be used by Novocure, its affiliates, and companies working with Novocure to develop future products, services, and programs. I understand that I may choose to no longer receive further communications from Novocure by following the unsubscribe instructions on the communication.

*Please note that we cannot provide you with medical advice or talk about personal treatment results because each person is different. Consult with your doctor for medical related questions.

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

What is Optune Lua approved to treat?

Optune Lua is a wearable, portable, FDA-approved device indicated for the treatment of adult patients, with unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM) to be used together with standard chemotherapy (pemetrexed and platinum-based chemotherapy).

Who should not use Optune for GBM or Optune Lua for MPM?

Optune for GBM and Optune Lua for MPM are not for everyone. Talk to your doctor if you have:

Do not use Optune for GBM or Optune Lua for MPM if you are pregnant or are planning to become pregnant. It is not known if Optune/Optune Lua is safe or effective during pregnancy.

What should I know before using Optune for GBM or Optune Lua for MPM?

Optune and Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune and Optune Lua.

What are the possible side effects of Optune for GBM and Optune Lua for MPM?

The most common side effects of Optune when used together with chemotherapy for GBM (temozolomide or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, seizure, and depression.

The most common side effects when using Optune alone for GBM were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

The most common side effects of Optune Lua when used together with chemotherapy for MPM (pemetrexed and platinum-based chemotherapy) were low red blood cell count, constipation, nausea, tiredness, chest pain, fatigue, skin irritation from device use, itchy skin, and cough.

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin irritation, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer.

Talk to your doctor if you have any of these side effects or questions.

Caution: Federal law restricts Optune Lua to sale by or on the order of a physician. Humanitarian Device. Authorized by Federal Law for use in the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma concurrently with pemetrexed and platinum-based chemotherapy. The effectiveness of this device for this use has not been demonstrated.

Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Please click here to see the Optune Lua IFU for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.